NOTES PAYABLE- UNRELATED THIRD PARTIES	6 Months Ended
Dec. 31, 2025
NOTES PAYABLE- UNRELATED THIRD PARTIES
NOTES PAYABLE- UNRELATED THIRD PARTIES	NOTE 11. NOTES PAYABLE- UNRELATED THIRD PARTIES Unrelated parties’ notes payable consist of convertible and non-convertible promissory notes. The aggregate gross principal amount outstanding under these notes was $555,395 and $401,780 as of December 31, 2025, and June 30, 2025, respectively. As of December 31, 2025, the Company recorded a debit discount of $119,275, primarily attributable to beneficial conversion features and/or original issue discounts associated with certain convertible instruments. No debt discount was outstanding as of June 30, 2025. After giving effect to the debt discount, net unrelated parties’ notes payable totaled $436,120 and $401,780 as of December 31, 2025 and June 30, 2025, respectively. These notes do not require regular monthly payments, but rather they are to be settled by the maturity date if not converted. (a) Convertible Note Payable - Unrelated Parties On July 1, 2024, the Company issued a private investor a $5,000 180-day Secured Convertible Promissory Note bearing interest at 10% per annum, convertible at $0.50 per share. In connection with the issuance, the Company granted 5,000 restricted common shares and a warrant to purchase 10,000 common shares at $0.75 per share. The Note, originally maturing on December 31, 2024, was extended to June 30, 2025, in exchange for an additional 5,250 restricted common shares and a warrant to purchase 10,500 common shares at $0.75 per share. On March 27, 2025, all warrants were exercised on a cashless basis, resulting in the issuance of 13,725 restricted common shares and the retirement of the warrants. On June 30, 2025, th3 Company issued the remaining 10,500 restricted common shares related to the extension. On June 30, 2025, the Company issued the remaining 10,500 restricted common shares related to the extension. The Note’s outstanding principal of $5,250 and accrued interest of $255 were fully paid during the quarter ended September 30, 2025, and no balance remained outstanding as of December 31, 2025. On September 29, 2023, the Company issued a private investor a $25,000 180-day Senior Secured Convertible Promissory Note, with an interest rate of 10%, convertible at $0.50 per share the lender’s discretion. The Note’s maturity date was March 27, 2024. As further inducement, the Company agreed to issue 25,000 shares of restricted common stock and a warrant to purchase 50,000 shares of restricted common stock, exercisable at $0.75 per share, any time prior to October 2, 2026, the warrant expiration date. On April 2, 2024, the note was extended for 180 days, and as inducement for extension, the Company agreed to issue 25,000 shares of restricted common stock and a warrant to purchase 50,000 shares of restricted common stock, exercisable at $0.75 per share, any time prior to April 2, 2027. On October 4, 2024, the note was extended again for 180 days, and as inducement for extension, the Company agreed to issue 25,000 shares of restricted common stock and a warrant to purchase 50,000 shares of restricted common stock, exercisable at $1.5 per share, any time prior to October 4, 2027. On January 1, 2025, the Company issued 75,000 restricted common stock shares which were obligated to issue as inducement in the note agreement. Further, all three warrants were redeemed through a cashless redemption on March 27, 2025, into 57,500 shares of the Company’s restricted common stock and were retired. On April 4, 2025, the note was extended again for 180 days, without any inducement, with maturity date of October 1, 2025. On June 30, 2025, the Company issued 108,031 restricted common stock shares which were obligated to issue as inducement in the note agreement. This Note was renewed on December 31, 2025, and together with accrued interest, the new face amount is due February 1, 2026. In addition, as further inducement to renew the note, the Company issued 26,696 restricted common stock shares. The principal balance owed on December 31, 2025, and June 30, 2025, was $26,696 and $25,000, respectively. The note’s accrued interest on December 31, 2025, and June 30, 2025, was $226 and $625, respectively. On July 1, 2024, the Company issued to a private investor a $36,624 180-day Secured Convertible Promissory Note bearing an interest rate of 10% per annum, which may be converted at $0.50 per share at the lender’s discretion. The Note’s maturity date is March 31, 2025. As further inducement to purchase this Note, the Company agreed to issue 36,624 restricted common stock shares and a warrant to purchase 73,248 shares of common stock exercisable at $0.75 per share, prior to June 30, 2027. The company issued 36,624 shares restricted common stock on January 1, 2025. This note was renewed on January 10, 2025, and the investor advanced another $15,000, so together with accrued interest the new face was $52,529 and is due March 31, 2025. In addition, as further inducement to renew the note, the Company agreed to issue 52,529 restricted common stock shares and a warrant to purchase 105,238 shares of common stock exercisable at $0.75 per share, prior to January 10, 2028. The warrants were redeemed through a cashless redemption on March 27, 2025, into 107,502 shares of the Company’s restricted common stock and were retired. On April 10, 2025, the note was extended again for 112 days, without any inducement, with maturity date of July 31, 2025. On September 1, 2025, the Note was again extended for an additional 45 days, also without inducement. This Note was renewed on December 31, 2025, the investor advanced another $5,000, so together with $3,333 of accrued interest, the new face amount was $57,175 and is due February 1, 2026. In addition, as further inducement to renew the note, the Company issued 62,176 restricted common stock shares. The principal balance owed on December 31, 2025, and June 30, 2025, was $62,176 and $53,842, respectively. The note’s accrued interest on December 31, 2025, and June 30, 2025, was $528 and $1,196, respectively. On January 9, 2025, the Company issued to a private investor a $10,000 Senior Secured Convertible Promissory Note bearing interest at 10% per annum and maturing on April 9, 2025. The note is convertible at the lender’s discretion at a rate of $0.50 per share. As a further inducement to purchase the note, the Company agreed to issue 10,000 restricted shares of common stock and a warrant to purchase 20,000 shares of common stock at an exercise price of $0.75 per share, exercisable any time prior to January 9, 2028. On April 10, 2025, the note was extended to a new maturity date of October 7, 2025, with no additional inducements granted. On June 30, 2025, the Company issued 10,000 restricted common stock shares which were obligated to issue as inducement in the note agreement. This Note was renewed on December 31, 2025, the investor advanced another $5,000, so together with $879 of accrued interest, the new face amount was $15,879 and is due February 1, 2026. In addition, as further inducement to renew the note, the Company issued 30,000 restricted common stock shares. The principal balance owed on December 31, 2025, and June 30, 2025, was $15,879 and $10,000, respectively. The note’s accrued interest on December 31, 2025, and June 30, 2025, was $137 and $472, respectively. On August 29, 2025, the Company issued to a private investor a $10,000 Convertible Promissory Note bearing interest at 15% per annum and maturing on October 28, 2025. The note is convertible at the lender’s discretion at a rate of $0.50 per share. As a further inducement to purchase the note, the Company agreed to issue 10,000 restricted shares of common stock. This Note was renewed on December 31, 2025, and together with $1,500 accrued interest, the new face amount was $11,500 and is due February 1, 2026. In addition, as further inducement to renew the note, the Company issued 11,500 restricted common stock shares. The principal balance owed on December 31, 2025, and June 30, 2025, was $11,500 and $0, respectively. The note’s accrued interest on December 31, 2025, and June 30, 2025, was $575 and $0, respectively. On September 10, 2025, the Company issued to a private investor a $10,000 Convertible Promissory Note bearing interest at 10% per annum and maturing on September 10, 2026. The note is convertible at the lender’s discretion at a rate of $0.50 per share. As a further inducement to purchase the note, the Company agreed to issue 10,000 restricted shares of common stock. On September 29, 2025, the Company issued 10,000 restricted shares of common stock which were obligated to issue as inducement in the note agreement. As of December 31, 2025, the principal balance was $10,000 and accrued interest was $383. On November 24, 2025, the Company issued a private investor a $10,000 Convertible Promissory Note bearing an interest rate of 10% per annum and maturing on November 19, 2026. This note is convertible at the lender’s discretion at a rate of $0.50 per share. As further inducement to purchase the note, the Company issued 10,000 restricted shares of common stock. As of December 31, 2025, the principal balance due was $10,000 and the accrued interest was $103. On August 29, 2025, the Company issued to a private investor a $20,000 Convertible Promissory Note bearing interest at 15% per annum and maturing on October 28, 2025. The note is convertible at the lender’s discretion at a rate of $0.50 per share. As a further inducement to purchase the note, the Company agreed to issue 20,000 restricted shares of common stock. On September 29, 2025, the Company issued 20,000 restricted stock shares which were obligated to issue as inducement in the note agreement. This note was renewed on December 1, 2025, and together with $3,000 accrued interest, the new face amount was $23,000 and is due February 1, 2026. In addition, as further inducement to renew the note, the Company issued 23,000 restricted common shares. The principal balance owed on December 31, 2025, and June 30,2025, the principal balance was $23,000 and $0, respectively. The note’s accrued interest on December 31, 2025, and June 30, 2025, was $1,150 and $0, respectively On September 5, 2025, the Company issued to a private investor a $10,000 Convertible Promissory Note bearing interest at 15% per annum and maturing on November 4, 2025. The note is convertible at the lender’s discretion at a rate of $0.50 per share. As a further inducement to purchase the note, the Company agreed to issue 10,000 restricted shares of common stock. On September 29, 2025, the Company issued 10,000 restricted shares of common stock which were obligated to issue as inducement in the note agreement. This note was renewed on December 1, 2025, and together with $1,500 accrued interest, the new face amount was $11,500 and is due February 1, 2026. In addition, as further inducement to renew the note, the Company issued 11,500 restricted stock shares. The principal balance owed on December 31, 2025, and June 30, 2025, was $11,500 and $0, respectively. The note’s accrued interest on December 31, 2025, and June 30, 2025, was $575 and $0, respectively. On August 29, 2025, the Company issued to a private investor a $50,000 Convertible Promissory Note bearing interest at 15% per annum and maturing on October 28, 2025. The note is convertible at the lender’s discretion at a rate of $0.50 per share. As a further inducement to purchase the note, the Company agreed to issue 50,000 restricted shares of common stock. On September 29, 2025, the Company issued 10,000 restricted shares of common stock which were obligated to issue as inducement in the note agreement. This Note was renewed on December 31, 2025, and together with $1,936 accrued interest, the new face amount was $51,937 and is due February 1, 2026. In addition, as further inducement to renew the note, the Company issued 51,936 restricted common stock shares. The principal balance owed on December 31, 2025, and June 30, 2025, was $51,936 and $0, respectively. The note’s accrued interest on December 31, 2025, and June 30, 2025, was $441 and $0, respectively. On October 29, 2025, the Company issued a private investor a $25,000 Convertible Promissory Note bearing interest at 15% per annum with maturity on December 28, 2025. The note is convertible at $0.50 per share. As a further inducement to purchase the note, the Company issued 25,000 restricted shares of common stock. This note is in default. As of December 31, 2025, the principal balance was $25,000 and the accrued interest was $958. See due to Note 9 “Related Parties Transactions” for additional senior secured convertible promissory notes issuances. (b) Note Payable – Unrelated Parties On March 5, 2025, the Company issued to the seller of the Orofino facility a $267,555 Secured Promissory Note bearing interest at 8% per annum and maturing on May 15, 2025. The note is secured by a first lien on the Orofino, Idaho property pursuant to a Deed of Trust. Under the terms of the agreement, upon default, the interest rate increases to 18% per annum, and a 15% late charge is applied to the outstanding principal. As the Company did not remit payment within ten days of the maturity date, the note went into default on May 25, 2025, and a late charge of $40,133 was added to the principal balance. The beneficiary filed a Notice of Default on September 24, 2025, under the Deed of Trust in Clearwater County, Idaho. The principal balance owed on December 31, 2025, and June 30, 2025, was $307,688 and $307,688, respectively. The note’s accrued interest on December 31, 2025, and June 30, 2025, was $38,414 and $10,414, respectively.

NOTES PAYABLE- UNRELATED THIRD PARTIES

6 Months Ended

Dec. 31, 2025

NOTES PAYABLE- UNRELATED THIRD PARTIES

NOTE 11. NOTES PAYABLE- UNRELATED THIRD PARTIES

Unrelated parties’ notes payable consist of convertible and non-convertible promissory notes. The aggregate gross principal amount outstanding under these notes was $555,395 and $401,780 as of December 31, 2025, and June 30, 2025, respectively.

As of December 31, 2025, the Company recorded a debit discount of $119,275, primarily attributable to beneficial conversion features and/or original issue discounts associated with certain convertible instruments. No debt discount was outstanding as of June 30, 2025. After giving effect to the debt discount, net unrelated parties’ notes payable totaled $436,120 and $401,780 as of December 31, 2025 and June 30, 2025, respectively.

These notes do not require regular monthly payments, but rather they are to be settled by the maturity date if not converted.

(a) Convertible Note Payable - Unrelated Parties

On July 1, 2024, the Company issued a private investor a $5,000 180-day Secured Convertible Promissory Note bearing interest at 10% per annum, convertible at $0.50 per share. In connection with the issuance, the Company granted 5,000 restricted common shares and a warrant to purchase 10,000 common shares at $0.75 per share. The Note, originally maturing on December 31, 2024, was extended to June 30, 2025, in exchange for an additional 5,250 restricted common shares and a warrant to purchase 10,500 common shares at $0.75 per share. On March 27, 2025, all warrants were exercised on a cashless basis, resulting in the issuance of 13,725 restricted common shares and the retirement of the warrants. On June 30, 2025, th3 Company issued the remaining 10,500 restricted common shares related to the extension. On June 30, 2025, the Company issued the remaining 10,500 restricted common shares related to the extension. The Note’s outstanding principal of $5,250 and accrued interest of $255 were fully paid during the quarter ended September 30, 2025, and no balance remained outstanding as of December 31, 2025.

On September 29, 2023, the Company issued a private investor a $25,000 180-day Senior Secured Convertible Promissory Note, with an interest rate of 10%, convertible at $0.50 per share the lender’s discretion. The Note’s maturity date was March 27, 2024. As further inducement, the Company agreed to issue 25,000 shares of restricted common stock and a warrant to purchase 50,000 shares of restricted common stock, exercisable at $0.75 per share, any time prior to October 2, 2026, the warrant expiration date. On April 2, 2024, the note was extended for 180 days, and as inducement for extension, the Company agreed to issue 25,000 shares of restricted common stock and a warrant to purchase 50,000 shares of restricted common stock, exercisable at $0.75 per share, any time prior to April 2, 2027. On October 4, 2024, the note was extended again for 180 days, and as inducement for extension, the Company agreed to issue 25,000 shares of restricted common stock and a warrant to purchase 50,000 shares of restricted common stock, exercisable at $1.5 per share, any time prior to October 4, 2027. On January 1, 2025, the Company issued 75,000 restricted common stock shares which were obligated to issue as inducement in the note agreement. Further, all three warrants were redeemed through a cashless redemption on March 27, 2025, into 57,500 shares of the Company’s restricted common stock and were retired. On April 4, 2025, the note was extended again for 180 days, without any inducement, with maturity date of October 1, 2025. On June 30, 2025, the Company issued 108,031 restricted common stock shares which were obligated to issue as inducement in the note agreement. This Note was renewed on December 31, 2025, and together with accrued interest, the new face amount is due February 1, 2026. In addition, as further inducement to renew the note, the Company issued 26,696 restricted common stock shares. The principal balance owed on December 31, 2025, and June 30, 2025, was $26,696 and $25,000, respectively. The note’s accrued interest on December 31, 2025, and June 30, 2025, was $226 and $625, respectively.

On July 1, 2024, the Company issued to a private investor a $36,624 180-day Secured Convertible Promissory Note bearing an interest rate of 10% per annum, which may be converted at $0.50 per share at the lender’s discretion. The Note’s maturity date is March 31, 2025. As further inducement to purchase this Note, the Company agreed to issue 36,624 restricted common stock shares and a warrant to purchase 73,248 shares of common stock exercisable at $0.75 per share, prior to June 30, 2027. The company issued 36,624 shares restricted common stock on January 1, 2025. This note was renewed on January 10, 2025, and the investor advanced another $15,000, so together with accrued interest the new face was $52,529 and is due March 31, 2025. In addition, as further inducement to renew the note, the Company agreed to issue 52,529 restricted common stock shares and a warrant to purchase 105,238 shares of common stock exercisable at $0.75 per share, prior to January 10, 2028. The warrants were redeemed through a cashless redemption on March 27, 2025, into 107,502 shares of the Company’s restricted common stock and were retired. On April 10, 2025, the note was extended again for 112 days, without any inducement, with maturity date of July 31, 2025. On September 1, 2025, the Note was again extended for an additional 45 days, also without inducement. This Note was renewed on December 31, 2025, the investor advanced another $5,000, so together with $3,333 of accrued interest, the new face amount was $57,175 and is due February 1, 2026. In addition, as further inducement to renew the note, the Company issued 62,176 restricted common stock shares. The principal balance owed on December 31, 2025, and June 30, 2025, was $62,176 and $53,842, respectively. The note’s accrued interest on December 31, 2025, and June 30, 2025, was $528 and $1,196, respectively.

On January 9, 2025, the Company issued to a private investor a $10,000 Senior Secured Convertible Promissory Note bearing interest at 10% per annum and maturing on April 9, 2025. The note is convertible at the lender’s discretion at a rate of $0.50 per share. As a further inducement to purchase the note, the Company agreed to issue 10,000 restricted shares of common stock and a warrant to purchase 20,000 shares of common stock at an exercise price of $0.75 per share, exercisable any time prior to January 9, 2028. On April 10, 2025, the note was extended to a new maturity date of October 7, 2025, with no additional inducements granted. On June 30, 2025, the Company issued 10,000 restricted common stock shares which were obligated to issue as inducement in the note agreement. This Note was renewed on December 31, 2025, the investor advanced another $5,000, so together with $879 of accrued interest, the new face amount was $15,879 and is due February 1, 2026. In addition, as further inducement to renew the note, the Company issued 30,000 restricted common stock shares. The principal balance owed on December 31, 2025, and June 30, 2025, was $15,879 and $10,000, respectively. The note’s accrued interest on December 31, 2025, and June 30, 2025, was $137 and $472, respectively.

On August 29, 2025, the Company issued to a private investor a $10,000 Convertible Promissory Note bearing interest at 15% per annum and maturing on October 28, 2025. The note is convertible at the lender’s discretion at a rate of $0.50 per share. As a further inducement to purchase the note, the Company agreed to issue 10,000 restricted shares of common stock. This Note was renewed on December 31, 2025, and together with $1,500 accrued interest, the new face amount was $11,500 and is due February 1, 2026. In addition, as further inducement to renew the note, the Company issued 11,500 restricted common stock shares. The principal balance owed on December 31, 2025, and June 30, 2025, was $11,500 and $0, respectively. The note’s accrued interest on December 31, 2025, and June 30, 2025, was $575 and $0, respectively.

On September 10, 2025, the Company issued to a private investor a $10,000 Convertible Promissory Note bearing interest at 10% per annum and maturing on September 10, 2026. The note is convertible at the lender’s discretion at a rate of $0.50 per share. As a further inducement to purchase the note, the Company agreed to issue 10,000 restricted shares of common stock. On September 29, 2025, the Company issued 10,000 restricted shares of common stock which were obligated to issue as inducement in the note agreement. As of December 31, 2025, the principal balance was $10,000 and accrued interest was $383.

On November 24, 2025, the Company issued a private investor a $10,000 Convertible Promissory Note bearing an interest rate of 10% per annum and maturing on November 19, 2026. This note is convertible at the lender’s discretion at a rate of $0.50 per share. As further inducement to purchase the note, the Company issued 10,000 restricted shares of common stock. As of December 31, 2025, the principal balance due was $10,000 and the accrued interest was $103.

On August 29, 2025, the Company issued to a private investor a $20,000 Convertible Promissory Note bearing interest at 15% per annum and maturing on October 28, 2025. The note is convertible at the lender’s discretion at a rate of $0.50 per share. As a further inducement to purchase the note, the Company agreed to issue 20,000 restricted shares of common stock. On September 29, 2025, the Company issued 20,000 restricted stock shares which were obligated to issue as inducement in the note agreement. This note was renewed on December 1, 2025, and together with $3,000 accrued interest, the new face amount was $23,000 and is due February 1, 2026. In addition, as further inducement to renew the note, the Company issued 23,000 restricted common shares. The principal balance owed on December 31, 2025, and June 30,2025, the principal balance was $23,000 and $0, respectively. The note’s accrued interest on December 31, 2025, and June 30, 2025, was $1,150 and $0, respectively

On September 5, 2025, the Company issued to a private investor a $10,000 Convertible Promissory Note bearing interest at 15% per annum and maturing on November 4, 2025. The note is convertible at the lender’s discretion at a rate of $0.50 per share. As a further inducement to purchase the note, the Company agreed to issue 10,000 restricted shares of common stock. On September 29, 2025, the Company issued 10,000 restricted shares of common stock which were obligated to issue as inducement in the note agreement. This note was renewed on December 1, 2025, and together with $1,500 accrued interest, the new face amount was $11,500 and is due February 1, 2026. In addition, as further inducement to renew the note, the Company issued 11,500 restricted stock shares. The principal balance owed on December 31, 2025, and June 30, 2025, was $11,500 and $0, respectively. The note’s accrued interest on December 31, 2025, and June 30, 2025, was $575 and $0, respectively.

On August 29, 2025, the Company issued to a private investor a $50,000 Convertible Promissory Note bearing interest at 15% per annum and maturing on October 28, 2025. The note is convertible at the lender’s discretion at a rate of $0.50 per share. As a further inducement to purchase the note, the Company agreed to issue 50,000 restricted shares of common stock. On September 29, 2025, the Company issued 10,000 restricted shares of common stock which were obligated to issue as inducement in the note agreement. This Note was renewed on December 31, 2025, and together with $1,936 accrued interest, the new face amount was $51,937 and is due February 1, 2026. In addition, as further inducement to renew the note, the Company issued 51,936 restricted common stock shares. The principal balance owed on December 31, 2025, and June 30, 2025, was $51,936 and $0, respectively. The note’s accrued interest on December 31, 2025, and June 30, 2025, was $441 and $0, respectively.

On October 29, 2025, the Company issued a private investor a $25,000 Convertible Promissory Note bearing interest at 15% per annum with maturity on December 28, 2025. The note is convertible at $0.50 per share. As a further inducement to purchase the note, the Company issued 25,000 restricted shares of common stock. This note is in default. As of December 31, 2025, the principal balance was $25,000 and the accrued interest was $958.

See due to Note 9 “Related Parties Transactions” for additional senior secured convertible promissory notes issuances.

(b) Note Payable – Unrelated Parties

On March 5, 2025, the Company issued to the seller of the Orofino facility a $267,555 Secured Promissory Note bearing interest at 8% per annum and maturing on May 15, 2025. The note is secured by a first lien on the Orofino, Idaho property pursuant to a Deed of Trust. Under the terms of the agreement, upon default, the interest rate increases to 18% per annum, and a 15% late charge is applied to the outstanding principal. As the Company did not remit payment within ten days of the maturity date, the note went into default on May 25, 2025, and a late charge of $40,133 was added to the principal balance. The beneficiary filed a Notice of Default on September 24, 2025, under the Deed of Trust in Clearwater County, Idaho. The principal balance owed on December 31, 2025, and June 30, 2025, was $307,688 and $307,688, respectively. The note’s accrued interest on December 31, 2025, and June 30, 2025, was $38,414 and $10,414, respectively.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 470
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/470/tableOfContent

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

+ Details

T-REX Acquisition Corp. 10-Q